The US FDA has granted fast track designation to FELIQS’ lead product FLQ-101 for preventing retinopathy of prematurity (ROP) ...

corporate finance and investing. Do you want your investment decisions to have a positive impact? Do you find it difficult to ...

Apply the tools of corporate finance to boost your strategic decision-making. Making the strategic decisions that will determine the future expansion, restructuring or capital requirements of your ...

The US FDA has granted orphan drug designation (ODD) to Modalis Therapeutics’ MDL-101, aimed at treating LAMA2-CMD.

WARMINSTER, Pa., Oct. 23, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ABUS), (“Arbutus” or the “Company”) a clinical-stage ...

OKYO Pharma has initiated the Phase II trial of OK-101, a treatment for neuropathic corneal pain (NCP), by dosing the first ...

Discover SocialFi, a revolutionary blend of social media and finance, offering true digital ownership, monetization, and ...